Home A case report and literature review of monoallelic mutation of GHR
Article
Licensed
Unlicensed Requires Authentication

A case report and literature review of monoallelic mutation of GHR

  • Marie Mitani , Hirohito Shima , Takeshi Sato , Tomohiro Inoguchi , Tsutomu Kamimaki , Maki Fukami ORCID logo and Tomonobu Hasegawa EMAIL logo
Published/Copyright: March 20, 2019

Abstract

Background

Monoallelic mutations of GHR have been described in idiopathic short stature (ISS), although the significance of these remain unclear. We report a case of ISS with novel monoallelic S219L mutation of GHR and discuss the possible significance of monoallelic GHR mutation in ISS.

Case presentation

The proband, a 13.9-year-old Japanese boy, had severe short stature (−3.8 standard deviation [SD]). Serum insulin-like growth factor (IGF)-I level and growth hormone (GH) secretion was normal. His parents were nonconsanguineous and had normal stature. Genetic analyses revealed a novel monoallelic missense variation in exon 7 of GHR (S219L). The proband’s mother had the same variation. S219L might be the novel mutation judging from there being no registration of it as a single-nucleotide polymorphism (SNP) in any database, evolutional conservation of Ser219, in silico analyses, and computational molecular visualization analysis. Furthermore, a review of the literature showed that the median height of missense mutation carriers of GHR was relatively low.

Conclusions

We propose the possibility that monoallelic mutation of GHR increases the susceptibility to short stature.


Corresponding author: Tomonobu Hasegawa, MD, PhD, Department of Pediatrics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan, Phone: +81-3-3353-1211, Fax: +81-3-5379-1978

Acknowledgments

This study was partly supported by a research grant from Japan Chemical Research (JCR) Pharmaceuticals.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This study was supported in part by a research grant from JCR pharmaceuticals.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interest: The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. David A, Hwa V, Metherell LA, Netchine I, Camacho-Hubner C, et al. Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. Endocr Rev 2011;32:472–97.10.1210/er.2010-0023Search in Google Scholar PubMed

2. Woods KA, Dastot F, Preece MA, Clark AJ, Postel-Vinay MC, et al. Phenotype: genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997;82:3529–35.10.1210/jc.82.11.3529Search in Google Scholar

3. Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, et al. Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med 1995;333:1093–8.10.1056/NEJM199510263331701Search in Google Scholar PubMed

4. Bonioli E, Taro M, Rosa CL, Citana A, Bertorelli R, et al. Heterozygous mutations of growth hormone receptor gene in children with idiopathic short stature. Growth Horm IGF Res 2005;15:405–10.10.1016/j.ghir.2005.08.004Search in Google Scholar PubMed

5. Hattori A, Katoh-Fukui Y, Nakamura A, Matsubara K, Kamimaki T, et al. Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature. Endocr J 2017;64:947–54.10.1507/endocrj.EJ17-0150Search in Google Scholar PubMed

6. Quinteiro C, Castro-Feijoo L, Loidi L, Barreiro J, de la Fuente M, et al. Novel mutation involving the translation initiation codon of the growth hormone receptor gene (GHR) in a patient with Laron syndrome. J Pediatr Endocrinol Metab 2002;15:1041–5.10.1515/JPEM.2002.15.7.1041Search in Google Scholar PubMed

7. Chen X, Song F, Dai Y, Bao X, Jin Y. A novel mutation of the growth hormone receptor gene (GHR) in a Chinese girl with Laron syndrome. J Pediatr Endocrinol Metab 2003;16:1183–9.10.1515/JPEM.2003.16.8.1183Search in Google Scholar

8. Amselem S, Duquesnoy P, Duriez B, Dastot F, Sobrier ML, et al. Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Hum Mol Genet 1993;2:355–9.10.1093/hmg/2.4.355Search in Google Scholar PubMed

9. Fang P, Riedl S, Amselem S, Pratt KL, Little BM, Haeusler G, et al. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygousmutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states. J Clin Endocrinol Metab 2007;92:2223–31.10.1210/jc.2006-2624Search in Google Scholar PubMed

10. Duquesnoy P, Sobrier ML, Duriez B, Dastot F, Buchanan CR, et al. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. Embo J 1994;13:1386–95.10.1002/j.1460-2075.1994.tb06392.xSearch in Google Scholar PubMed PubMed Central

11. Jorge AA, Souza SC, Arnhold IJ, Mendonca BB. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration. Clin Endocrinol (Oxf) 2004;60:36–40.10.1111/j.1365-2265.2004.01930.xSearch in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2018-0365).


Received: 2018-08-18
Accepted: 2019-01-29
Published Online: 2019-03-20
Published in Print: 2019-04-24

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. The importance of anthropological methods in the diagnosis of rare diseases
  4. Original Articles
  5. PON1 arylesterase activity, HDL functionality and their correlation in malnourished children
  6. Prevalence of dyslipidemia and factors affecting dyslipidemia in young adults with type 1 diabetes: evaluation of statin prescribing
  7. Myocardial dysfunction in relation to serum thiamine levels in children with diabetic ketoacidosis
  8. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves’ disease: a single-center experience
  9. Endocrine consequences of neuroblastoma treatment in children: 20 years’ experience of a single center
  10. Analysis of diabetes-associated autoantibodies in children and adolescents with autoimmune thyroid diseases
  11. Adrenal function of extremely premature infants in the first 5 days after birth
  12. Atypical presentation of Leydig cell tumour in three prepubertal patients: diagnosis, treatment and outcomes
  13. The diagnosis of cystinosis in patients reveals new CTNS gene mutations in the Chinese population
  14. Comparing the validity of continuous metabolic syndrome risk scores for predicting pediatric metabolic syndrome: the CASPIAN-V study
  15. Primary pigmented nodular adrenocortical disease (PPNAD): single centre experience
  16. Short Communication
  17. Classical galactosemia patients can achieve high IQ scores
  18. Case Reports
  19. Idiopathic gonadotropin-independent precocious puberty – is regular surveillance required?
  20. MYT1L mutation in a patient causes intellectual disability and early onset of obesity: a case report and review of the literature
  21. A case report and literature review of monoallelic mutation of GHR
  22. Pitfalls in the diagnosis of insulin autoimmune syndrome (Hirata’s disease) in a hypoglycemic child: a case report and review of the literature
Downloaded on 2.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0365/html
Scroll to top button